Ascentage Pharma Group Financials - Benzinga

Ascentage Pharma Group International

AAPGNASDAQ

Trade with Public

Trade with Public

$18.28

-0.45-2.42%

At close: Aug 28, 5:00 PM EST

$18.38

0.100.57%

After Hours: Aug 27, 9:29 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

Ascentage Pharma Group Financials

Ascentage Pharma Group (AAPG) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate

Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.24) per

Benzinga Newsdesk

Earnings Scheduled For March 25, 2026

Benzinga Insights

Earnings Scheduled For August 20, 2025

Benzinga Insights

Earnings Scheduled For March 27, 2025

Benzinga Insights